Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
August 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
4 | 5 | 6 | 7 | 8 | 9 | 10 |
11 | 12 | 13 | 14 | 15 | 16 | 17 |
18 | 19 | 20 | 21 | 22 | 23 | 24 |
25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on July 9, 2025

Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements
CAMBRIDGE, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has regained compliance with Nasdaq for …

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
NEEDHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

‘Lavender & The Butterfly Nation’ Pushes Boundaries with World’s First GenAI-Hybrid Animated Feature
LONDON, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a boundary-pushing GenAI creative studio, unveils its pioneering animated feature, Lavender …

‘Lavender & The Butterfly Nation’ Breaks Ground as World’s First GenAI-Hybrid Animated Feature Blending AI with Human Emotion
HOLLYWOOD, July 09, 2025 (GLOBE NEWSWIRE) -- IMAGENai Inc., a visionary GenAI creative studio, introduces “Lavender …

Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib
- Newly issued U.S. composition of matter patent expected to provide exclusivity into 2042, with subsequent opportunity for patent term extension - - First U.S. patent granted on a deep cyclic inhibitor: a once-daily pill that aims to drive longer-lasting …

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity
-- Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reductions in bivamelagon trial were consistent with BMI …

Auddia Announces Leadership Changes and Special Committee to Evaluate Business Combination and Restructuring as AI Native Holding Company
Jeff Thramann, Executive Chairman of Auddia, has succeeded Michael Lawless, who is retiring, as CEO to oversee restructuring New independent board members with experience in AI infrastructure and the evaluation of entrepreneurial ventures added to form a …

Sanoma will publish its Half-Year Report 2025 on 30 July
Sanoma Corporation, Press Release, 9 July 2025 at 11:00 EET Sanoma will publish its Half-Year Report 2025 on 30 July Sanoma will publish its Half-Year Report 2025 on Wednesday 30 July 2025 at approx. 8:30 EET. The report and related materials will be …

Sanoma julkaisee vuoden 2025 puolivuosikatsauksensa 30.7.
Sanoma Oyj, lehdistötiedote, 9.7.2025 klo 11.00 Sanoma julkaisee vuoden 2025 puolivuosikatsauksensa 30.7. Sanoma julkaisee vuoden 2025 puolivuosikatsauksensa keskiviikkona 30.7.2025 n. klo 8.30. Raportti ja siihen liittyvät materiaalit ovat saatavilla …

Gray Announces Upsizing and Pricing of $900 Million of 9.625% Senior Secured Second Lien Notes due 2032
ATLANTA, July 08, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today the pricing of its previously announced private offering of $900 million aggregate principal amount of 9.625% senior secured second lien notes due 2032 (the “ …